TradeUP Acquisition Corp. (UPTD) Adds $6.8M PIPE to Estrella Deal
by Nicholas Alan Clayton on 2023-07-26 at 8:55am

TradeUP (NASDAQ:UPTD) announced in an 8-K this morning that it has added a $6.8 million PIPE to its combination with Estrella Biopharma, which will wipe an equal amount of debt from its books.

Eureka Therapeutics, which was owed $6.8 million by Estrella, will instead receive 680,000 Class B units, each consisting of one common TradeUp share and one preferred share.

While these common TradeUp shares will convert to Estrella shares at the business combination’s close, the preferred shares will do so six months later. These will convert to a number of shares equal to $10 minus the greater of the stock’s last closing price or its 20-day VWAP. In no case will the conversion price be less than $4.15.

Eureka has also agreed to a one-year lock-up for all shares received as a part of this arrangement. So, it gains some downside protection and higher upside on its debt while Estrella gets to enter the public markets with a cleaner balance sheet.

TradeUp initially announced its $398 million combination with Estrella Biopharma in October 2022. Emeryville, California-based Estrella is developing three potential cancer therapies aimed at improving the effectiveness of T-cell treatments.

The SPAC secured a one-year extension of its transaction deadline earlier this month to continue working on the deal and will contribute $0.05 per share monthly moving forward. Redemptions from this vote expanded its total shares redeemed to 83.1%, however, leaving it with just $7.9 million in trust.

TradeUp must provide at least $20 million in cash in order for the deal to close. In April, White Lion Capital agreed to purchase up to $50 million in shares of the combined company after close through a common stock purchase agreement.

Recent Posts
by Kristi Marvin on 2024-04-20 at 11:45am

Terms Tracker for the Week Ending April 19, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Passover and school spring break starts next week, which most likely means a slowdown in SPAC filing activity. Although Churchill IX is now rumored to...

by Nicholas Alan Clayton on 2024-04-19 at 3:00pm

Despite a week of general pull-backs in the market, fintech firm Ibotta (NYSE:IBTA) nonetheless took the dive and had a good week debuting via a traditional IPO in the choppy waters. The company, which provides app-based consumer cashback discounts on purchases, priced its IPO at $88, above its proposed range of $76 to $84, and...

by Nicholas Alan Clayton on 2024-04-19 at 7:53am

At the SPAC of Dawn Happy Friday! SPACInsider has unveiled new presets on SPAC Performance accessible via the Data drop-down to easily sort for the highest and lowest performing active SPACs and de-SPACs. On the de-SPAC side, Vertiv (NYSE:VRT) continues to be well ahead of the pack, logging a 710% return by share price adjusted...

by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved